Compare 10X Genomics Inc (TXG) vs Ventas Inc. Common Stock (VTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Ventas Inc. Common Stock — how do they compare? 10X Genomics Inc trades at $79 (market cap $10.07B), while Ventas Inc. Common Stock trades at $82.53 (market cap $41.94B). The key difference: Ventas Inc. Common Stock is far larger — about 4.2× 10X Genomics Inc's market cap, and Ventas Inc. Common Stock pays a 2.54% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 92 Days and Ventas Inc. Common Stock for 0 Days on average.
| TXG | VTR | |
|---|---|---|
Market Cap | $10.07B | $41.94B |
Volume | 5,657,286 | 4,588,793 |
Sector | Health | Real Estate |
52-Week High | $97.74 | $100.53 |
52-Week Low | $11.48 | $67.45 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | $9.59B | $54.66B |
Dividend Yield | — | 2.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
10x Genomics (TXG) trades at $76.10, down 5.65% on the day, as technical indicators signal bearish momentum with the stock below key resistance levels. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive operating cash flow of $136M in 2025, though it remains unprofitable with a -12.18% net margin. Recent developments include the launch of Atera spatial biology platform shipments and a patent victory against Parse Biosciences.
TXG presents a mixed investment case with strong product innovation and improving financial trends offset by high valuation metrics and persistent losses. The stock's risk/reward appears balanced near analyst consensus targets, requiring successful execution on Atera commercialization and path to profitability to justify current multiples.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Ventas Inc. Common Stock
Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →
